Developed and manufactures a novel, biomaterial which utilizes hydrogel nanoparticles which aggregate to form a material of varying strength and elasticity which has extensive medical application including wound management and burn care, tissue regeneration and drug delivery devices.
An international corporation that designs, manufacturers and markets equipment and materials for industrial applications of vacuum technology. The company also produces nanoparticulate pastes and nanometal inks.
A developer and producer of the MMA - MEMS Motion Analyzer™ product family. These tools enable researchers to visualize and quantify three-dimensional surfaces and motions from millimeters to Angstroms.
An R&D company to identify, develop, and commercialize breakthrough technologies in the field of energy storage and energy conversion devices which exploit the extraordinary properties of nanostructured materials.
A solutions oriented R&D company that specializes in identifying, developing, and commercializing new and emerging technologies and products for integration into the security, defense and health and safety markets.
UT Dots Inc. is a nanotechnology research and manufacturing company based at the University of Illinois Research Park at Champaign, Illinois. The company specializes in manufacturing high quality silver and gold nanoinks. Their current technology enables continuous production of nanoparticles of desired chemical nature and quality from aerosol.
Varian's scientific instruments and vacuum technologies, consumable supplies, and solutions are key tools in bio-molecular and academic research, pharmaceutical R&D and manufacturing, and industrial R&D and quality control.
Vascular Magnetics, Inc. is magnetically targeting drug-loaded biodegradable nanoparticles to develop Vascular Magnetic Intervention (VMI), a novel therapy for peripheral artery disease (PAD). PAD is a common chronic condition characterized by obstruction (stenosis) of the arteries in the legs.
The company is developing Drug-Coated Balloons (DCB) that are designed to be a more precise delivery vehicle and be the standard treatment of choice for vascular atherosclerosis as well as non-vascular applications.
Velocys, Inc. is commercializing revolutionary processing systems, including nanoscale ones, that provide energy companies with new synthetic fuels and chemical companies with substantial capital cost savings, improved product yields, and greater energy efficiencies.